MCM
FBIO icon

Montibus Capital Management’s Fortress Biotech FBIO Stock Holding History

Montibus Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2.74M Sell
26,092
-2,685
-9% -$329K 0.3% 89
2013
Q2 		$3.71M Buy
+28,777
New +$4.24M 0.47% 86

Other funds holding FBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Montibus Capital Management's FBIO Position: Q3 2013 in Review

Montibus Capital Management reduced its Fortress Biotech (FBIO) stake by 9.3% in Q3 2013, selling an estimated $329K and leaving 26,092 shares worth $2.74M. The position accounts for 0.3% of the portfolio, ranked #89.

Montibus Capital Management first reported a position in FBIO in Q2 2013 and has held it in 2 quarters since. The position peaked at $3.71M in Q2 2013. 81 funds tracked by Wall St. Rank hold FBIO as of Q3 2013.

  • Montibus Capital Management held 26,092 shares of Fortress Biotech worth $2.74M as of Q3 2013.
  • Montibus Capital Management sold 2,685 Fortress Biotech shares in Q3 2013, an estimated $329K.
  • Fortress Biotech made up 0.3% of Montibus Capital Management's portfolio in Q3 2013, its #89 holding.
  • Montibus Capital Management first reported a position in Fortress Biotech in Q2 2013 and has held it in 2 quarters since.
  • Montibus Capital Management's Fortress Biotech position peaked at $3.71M in Q2 2013.
  • 81 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2013.

Based on Montibus Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.